v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Losses
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   97,377,121      
Beginning balance at Dec. 31, 2023 $ 133,071 $ 2 $ 624,414 $ (15) $ (491,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)   22,560,001      
Issuance of common stock 132,055   132,055    
Issuance of pre-funded warrants, net of issuance costs of $1.2 million 18,800   18,800    
Issuances of common stock under the employee stock purchase plan (in shares)   74,488      
Issuances of common stock under the employee stock purchase plan 436   436    
Issuance of common stock upon exercise of stock options (in shares)   9,664      
Issuance of common stock upon exercise of stock options 36   36    
Stock-based compensation expense 5,209   5,209    
Change in unrealized loss on investments, net of tax (80)     (80)  
Net loss (45,761)       (45,761)
Ending balance (in shares) at Mar. 31, 2024   120,021,274      
Ending balance at Mar. 31, 2024 243,766 $ 2 780,950 (95) (537,091)
Beginning balance (in shares) at Dec. 31, 2023   97,377,121      
Beginning balance at Dec. 31, 2023 133,071 $ 2 624,414 (15) (491,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Change in unrealized loss on investments, net of tax (56)        
Net loss (101,088)        
Ending balance (in shares) at Jun. 30, 2024   120,030,813      
Ending balance at Jun. 30, 2024 196,589 $ 2 789,076 (71) (592,418)
Beginning balance (in shares) at Mar. 31, 2024   120,021,274      
Beginning balance at Mar. 31, 2024 243,766 $ 2 780,950 (95) (537,091)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   9,539      
Issuance of common stock upon exercise of stock options 35   35    
Stock-based compensation expense 8,091   8,091    
Change in unrealized loss on investments, net of tax 24     24  
Net loss (55,327)       (55,327)
Ending balance (in shares) at Jun. 30, 2024   120,030,813      
Ending balance at Jun. 30, 2024 $ 196,589 $ 2 789,076 (71) (592,418)
Beginning balance (in shares) at Dec. 31, 2024 131,160,842 131,160,842      
Beginning balance at Dec. 31, 2024 $ 153,149 $ 2 840,358 1 (687,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 5,681   5,681    
Change in unrealized loss on investments, net of tax (16)     (16)  
Net loss (51,890)       (51,890)
Ending balance (in shares) at Mar. 31, 2025   131,160,842      
Ending balance at Mar. 31, 2025 $ 106,924 $ 2 846,039 (15) (739,102)
Beginning balance (in shares) at Dec. 31, 2024 131,160,842 131,160,842      
Beginning balance at Dec. 31, 2024 $ 153,149 $ 2 840,358 1 (687,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 0        
Change in unrealized loss on investments, net of tax $ (11)        
Net loss $ (104,481)        
Ending balance (in shares) at Jun. 30, 2025 134,494,438 134,494,438      
Ending balance at Jun. 30, 2025 $ 60,860 $ 2 852,561 (10) (791,693)
Beginning balance (in shares) at Mar. 31, 2025   131,160,842      
Beginning balance at Mar. 31, 2025 106,924 $ 2 846,039 (15) (739,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of pre-funded warrants (in shares)   3,199,984      
Issuances of common stock under the employee stock purchase plan (in shares)   133,612      
Issuances of common stock under the employee stock purchase plan 197   197    
Stock-based compensation expense 6,325   6,325    
Change in unrealized loss on investments, net of tax 5     5  
Net loss $ (52,591)       (52,591)
Ending balance (in shares) at Jun. 30, 2025 134,494,438 134,494,438      
Ending balance at Jun. 30, 2025 $ 60,860 $ 2 $ 852,561 $ (10) $ (791,693)